- Home
- ARCT vs NPKI Comparison
ARCT vs NPKI Comparison
Compare ARCT & NPKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- NPKI
- Stock Information
- Founded
- ARCT 2013
- NPKI 1932
- Country
- ARCT United States
- NPKI United States
- Employees
- ARCT N/A
- NPKI N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- NPKI Metal Fabrications
- Sector
- ARCT Health Care
- NPKI Industrials
- Exchange
- ARCT Nasdaq
- NPKI Nasdaq
- Market Cap
- ARCT 487.0M
- NPKI 634.0M
- IPO Year
- ARCT N/A
- NPKI N/A
- Fundamental
- Price
- ARCT $17.31
- NPKI $7.37
- Analyst Decision
- ARCT Strong Buy
- NPKI
- Analyst Count
- ARCT 7
- NPKI 0
- Target Price
- ARCT $65.00
- NPKI N/A
- AVG Volume (30 Days)
- ARCT 422.7K
- NPKI 499.4K
- Earning Date
- ARCT 03-06-2025
- NPKI 02-19-2025
- Dividend Yield
- ARCT N/A
- NPKI N/A
- EPS Growth
- ARCT N/A
- NPKI N/A
- EPS
- ARCT N/A
- NPKI N/A
- Revenue
- ARCT $160,399,000.00
- NPKI $748,372,000.00
- Revenue This Year
- ARCT $7.33
- NPKI N/A
- Revenue Next Year
- ARCT $4.71
- NPKI N/A
- P/E Ratio
- ARCT N/A
- NPKI N/A
- Revenue Growth
- ARCT N/A
- NPKI 93.70
- 52 Week Low
- ARCT $14.30
- NPKI $5.61
- 52 Week High
- ARCT $45.00
- NPKI $8.65
- Technical
- Relative Strength Index (RSI)
- ARCT 48.23
- NPKI N/A
- Support Level
- ARCT $16.01
- NPKI N/A
- Resistance Level
- ARCT $21.26
- NPKI N/A
- Average True Range (ATR)
- ARCT 1.37
- NPKI 0.00
- MACD
- ARCT 0.21
- NPKI 0.00
- Stochastic Oscillator
- ARCT 40.60
- NPKI 0.00
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.